
When science begins to rethink the aging brain through a simple spray
Early research suggests nasal spray-based treatments may influence brain aging in experimental models, but human application is not yet confirmed.

Early research suggests nasal spray-based treatments may influence brain aging in experimental models, but human application is not yet confirmed.

Researchers are improving CAR T-cell cancer therapy using stem cell approaches to enhance effectiveness and precision.

Canada and the Bahamas introduce travel restrictions and screening measures following renewed Ebola outbreaks in Africa.

Uganda confirms new Ebola cases as WHO strengthens regional preparedness and containment measures.

Health officials warn that the Ebola outbreak in Congo is spreading rapidly, challenging regional healthcare systems and emergency response efforts

Scientists are developing a non-laser eye correction technology using electrical pulses and specialized lenses to improve vision treatment.

New research suggests long COVID symptoms may involve multiple biological mechanisms beyond brain inflammation alone.

The American Cancer Society now includes blood testing among recommended colorectal cancer screening options to improve access and early detection.

A new study suggests mosquitoes may learn to associate DEET repellents with feeding, though experts still recommend repellents as effective protection.

A new five-level disaster alert system aims to provide clearer, tiered communication, helping the public navigate extreme weather while integrating critical health risk management strategies.
.jpeg&w=3840&q=75)
New research shows that regularly consuming beans and soy can reduce high blood pressure risk by nearly 30%, highlighting the protective cardiovascular effects of these nutrient-dense plant staples.

Rising global temperatures are creating new environments that facilitate the growth of antibiotic-resistant Salmonella. This environmental shift complicates global public health efforts.

A massive genetic analysis of 500 feline tumors has revealed striking similarities to human cancer mutations, providing a valuable comparative model to accelerate future oncology treatments.

Japan’s low birthrate stems from a clash between rigid traditional gender roles and modern life. Structural workplace demands and unequal domestic burdens hinder family growth, defying simple fixes.

Scientists have successfully engineered Natural Killer cells to bypass tumor evasion tactics, creating a more potent immune defense against aggressive cancer cells through genetic refinement.

Senior-to-senior care programs, supported by digital health technology, are emerging as an innovative way to address the global aging challenge, fostering community and autonomy.

New research identifies blood-based protein markers that can predict psychosis risk in youth with high accuracy, offering a promising tool for early psychiatric intervention.

Respiratory virus activity, including flu, RSV, and COVID-19, has reached low, baseline levels globally, marking a period of stability in public health across the spring season.

Community-based initiatives and solidarity events are increasingly vital for childhood cancer survivors, providing peer support and psychosocial connection after treatment ends.

New genomic studies have identified specific gene variants that influence fat metabolism in the liver, linking fatty liver disease to increased risks for diabetes and obesity.

Modern clinics are increasingly collaborating with traditional Chinese medicine practitioners to provide integrative, patient-centered care for managing complex, long-term chronic conditions.

New research reveals that GLP-1 drugs like Ozempic may reshape neural connections in the brain's salience network, potentially influencing attention, reward pathways, and long-term brain health.

A Phase 3 study published in JAMA Neurology shows that the investigational drug ecopipam effectively maintains tic control and halves the risk of relapse in children with Tourette syndrome.

Clinical trials published in the NEJM demonstrate that BioVAT, an engineered stem cell heart patch, can integrate with damaged heart tissue, improving function and quality of life in heart failure.